Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Learn what to ask a retirement planning expert to maximize your financial potential. Equip yourself with the right questions for success.
13,955 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Oil climbs to the upper $90s per barrel as defense spending expands and aviation MRO demand stays tight. Analysts say...
Palantir stock has faced volatility, but March is showing momentum. This deep dive explores why March could turning p...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
Investors are watching CoreWeave's stock slide after a rapid rise. This guide breaks down whether the dip is a buying...
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...
earnings week brings big questions for Micron. The real driver isn’t a guess on revenue alone—it's AI memory demand....
A 1949 recording captures the oldest known humpback song off Bermuda, offering a window into an ocean once times quie...
As Semtech gears up for its 2026 results, investors want concrete takeaways on growth drivers, margins, and capital d...
Markets toppled and surged in swings as investors assessed a policy path that some say appears improvised. Analysts w...
RunSybil secures $40 million in a funding round led by Khosla Ventures, backing its autonomous AI agents that hack li...